HAEMONETICS CORP Action · US4050241003 · HAE · 881782 (XNYS) USA · Healthcare — cotations et cours en temps réel, données d'entreprise, dividendes, fondamentaux et analyse de portefeuille IA sur MoneyPeak

Aperçu

Analyse alimentée par l’IA

Analyse fondamentale

Découvrez ce que disent vraiment les chiffres — avant le marché

Analyser maintenant

Sentiment des actualités

Les actualités d’aujourd’hui sont-elles un signal d’achat ou un avertissement ?

Analyser maintenant

Acheter / Conserver / Vendre

Faut-il acheter, conserver ou vendre ? Obtenez l’avis de l’IA dès maintenant.

Analyser maintenant

Évaluation des risques

Détectez les risques cachés avant qu’ils n’impactent votre portefeuille.

Analyser maintenant

Juste valeur

Cette action est-elle bon marché, correctement valorisée ou surévaluée ?

Analyser maintenant

Dernières analyses d’IA sur HAEMONETICS CORP

Résumé de la Note des Analystes

Achat

Achat fort

Achat

Conserver

Vente

Vente forte

Pas de cours

25.05.2026 05:27

Cours actuels de HAEMONETICS CORP

Bourse	Ticker	Devise	Dernier échange	Cours	Variation journalière
Quotrix	HCRSDL03.DUSD	EUR	25.05.2026 05:27	57,00 EUR	1,50 EUR +2,70 %
NYSE	HAE	USD	22.05.2026 20:00	65,49 USD	-
IEX	HAE	USD	22.05.2026 19:59	65,43 USD	-
Düsseldorf	HCRSDL03.DUSB	EUR	21.05.2026 17:31	52,50 EUR	-

Notation du Risque ESG

B Bon

Flottant et Liquidité des Actions

Flottant Libre 98,80 %

Actions en Flottant 44,9 M

Actions en Circulation 45,45 M

Fonds investis

Les fonds suivants ont investi dans HAEMONETICS CORP :

Fonds State Street SPDR S&P Health Care Equipment ETF	Vol. en millions 13.484,31	Part (%) 1,67 %
Fonds Janus Henderson Small Cap Growth Alpha ETF	Vol. en millions 1.130,94	Part (%) 0,77 %
Fonds Janus Henderson Small/Mid Cap Growth Alpha ETF	Vol. en millions 1.300,26	Part (%) 0,70 %
Fonds Hartford Multifactor Small Cap ETF	Vol. en millions 154,57	Part (%) 0,61 %
Fonds Etho Climate Leadership U.S. ETF	Vol. en millions 542,02	Part (%) 0,32 %

Profil de l'entreprise pour HAEMONETICS CORP Action

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.